Progesterone Resistance Clinical Trial
Official title:
Impact of Step-down Approach During Late Follicular Phase in Recombinant FSH-stimulation Dosage for IVF on Progesterone Level on the Day of Final Oocyte Maturation
Step-down approach and late follicular phase progesterone level
The study will be performed using the stimulation medication Gonal-F which is a recombinant
FSH-preparation. Due to application as pen-device, it allows reduction of the stimulation
dosage in steps of 12.5IU.
It is important to evaluate the dynamics of progesterone-rise after final oocyte maturation,
as this dynamic might also have an influence on the receptivity of the endometrium.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03519776 -
Variation of Progesterone in IVF Cycles
|
||
Recruiting |
NCT06390904 -
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients
|
Phase 2/Phase 3 | |
Recruiting |
NCT05316935 -
GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients
|
Phase 2/Phase 3 | |
Recruiting |
NCT06379113 -
GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients
|
Phase 2/Phase 3 | |
Completed |
NCT03930212 -
Progesterone Supplementation in Threatened Abortion
|
Phase 4 | |
Completed |
NCT05062135 -
Progesterone Action on Endometrium of PCOS
|
N/A |